Comparative efficacy and safety of deferoxamine, deferiprone and deferasirox on severe thalassemia: a meta-analysis of 16 randomized controlled trials.
<h4>Objective</h4>A meta-analysis was conducted to investigate the efficacy and safety of three main iron chelators, namely, deferoxamine (DFO), deferiprone (DFP) and deferasirox (DFX) for thalassemia major (TM) patients.<h4>Methods</h4>Randomized controlled trials comparing...
Guardado en:
Autores principales: | Sujian Xia, Weidong Zhang, Liting Huang, Hong Jiang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/948cbca33a674635a10f19bad6384754 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
An overview of complications associated with deferoxamine therapy in thalassemia
por: Bijan Keikhaei, et al.
Publicado: (2021) -
Safety and efficacy of thalidomide in patients with transfusion-dependent β-thalassemia: a randomized clinical trial
por: Jiang-Ming Chen, et al.
Publicado: (2021) -
Iron chelation therapy with deferiprone improves oxidative status and red blood cell quality and reduces redox-active iron in β-thalassemia/hemoglobin E patients
por: Noppawan Phumala Morales, et al.
Publicado: (2022) -
Efficacy and safety of stenting for elderly patients with severe and symptomatic carotid artery stenosis: a critical meta-analysis of randomized controlled trials
por: Ouyang YA, et al.
Publicado: (2015) -
Efficacy and Safety of Chinese Medicine in Treating Arrhythmia: Meta-Analysis of Randomized Controlled Trials
por: Hanyu He, et al.
Publicado: (2021)